Nebenwirkungen · Tasmar
Tasmar 100 mg film-coated tablets · Abschnitt 4.8 · PDF-Seite 8
HOS-086581 · Präparat HOS-083306
System organ class Incidence Adverse Events Infections and infestations Common Upper respiratory tract infection Psychiatric disorders Very common Sleep disorder Dreaming excessive Somnolence Confusion Hallucination Rare Impulse control disorders* (Libido increased, hypersexuality, pathological gambling, compulsive spending or buying, binge eating, compulsive eating (see section 4.4)) Nervous system disorders Very common Dyskinesia Dystonia Headache Dizziness Somnolence Orthostatic complaints Rare Neuroleptic Malignant Syndrome Symptom Complex (see section 4.4) Common Hypokinesia Syncope Gastrointestinal disorders Very common Nausea Diarrhoea Common Vomiting Constipation Xerostomia Abdominal pain Dyspepsia Metabolism and nutrition Very common Anorexia disorders Skin and subcutaneous tissue Common Sweating increased disorders Renal and urinary disorders Common Urine discoloration
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2025-09-10T13:49:00Z · SHA-256 8ce859140f9a095e62d5fef3a3e25bd89320c57ae3e287a376abb5c14d6c4437 · Passage b21009eecc639d2b7f1eb05d78346619f82bee895ff9fe53b58eddea3e4fb739 · Zeichen 1332–3785 im Abschnitt